Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees97
Employees97
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees97
Employees97
NBTX Key Statistics
Market cap1.79B
Market cap1.79B
Price-Earnings ratio-58.73
Price-Earnings ratio-58.73
Dividend yield—
Dividend yield—
Average volume69.52K
Average volume69.52K
High today$33.88
High today$33.88
Low today$33.43
Low today$33.43
Open price$33.62
Open price$33.62
Volume58.34K
Volume58.34K
52 Week high$41.89
52 Week high$41.89
52 Week low$3.13
52 Week low$3.13
NBTX News
TipRanks 3d
Nanobiotix: Platform Expansion Potential and Risk-Adjusted NBTXR3 Valuation Support Buy RatingAnalyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Nanobiotix and keeping the price target at €34.00. Unlock hedge fund-level data...
TipRanks 5d
Nanobiotix Unveils Preclinical Data Showing Nanoprimer Boosts LNP-DNA Cancer ImmunotherapyUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.